NKX2-3 and acute myeloid leukemia: Recently, we reported that NKL homeodomain factors NKX2-3 and NKX2-4 deregulate megakaryocytic-erythroid differentiation factor FLI1 in AML, which shows conspicuous downregulation in MEPs (Figure S8) [35].